BackAddex Therapeutics Overview

Addex Therapeutics Receivables

Track Addex Therapeutics's receivables ($30K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$29746.00
↓ 22.62% YoYΔ $-8693.00 vs prior year quarter

Peer trimmed avg / median

Loading

Addex Therapeutics Receivables History

Loading

Addex Therapeutics vs. peers: Receivables Comparison

Loading

Addex Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Addex Therapeutics (ADDXF) FAQ

Addex Therapeutics (ADDXF) currently reports a receivables of $30K as of June 2026. That compares with $38K in the prior-year period — down 22.6% year over year. Use the charts on this page to explore Addex Therapeutics's receivables history and peer comparisons.

Addex Therapeutics's receivables decreased from $38K to $30K — a 22.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Addex Therapeutics reported $30K in receivables as of June 2026. That compares with $38K in the prior-year period — down 22.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $30K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Addex Therapeutics, and consider following ADDXF for alerts when major investors trade the stock.

Addex Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $30K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADDXF with unrelated industries.